ARCHIVES

Also FDA clarifies data requirements for phase I IND applications.

This article is from The Cancer Letter archive.

Vol. 31 No. 17 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Breast Density Does Not Raise Breast Cancer Death Rates

August 31, 2012

Cancer, AIDS Drug Screening Contracts Ok’d For Recompetition

February 28, 1992

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

July 26, 2013

Nixon Tells ACCC U.S., USSR Should Be Allies In War Against Cancer

April 11, 1986

Final Regulations For Clinical Cancer Education Program Adopted

October 3, 1975

NCI Programs: NCI Seeks Nominations For director’s Consumer Liaison Group

August 6, 1999